Clinical trial
Investigation of Cytokine Change and Its Prognostic Value in Patients With Hepatocellular Carcinoma Treated by Thermal Ablation
NCT04555265 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Cytokine Change and Its Prognostic Value in Patients With Hepatocellular Carcinoma Treated by Thermal Ablation
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2020
- Completion date
- July 31, 2023
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma